Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
Real-time insight on key fixed income and fx markets.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- Political RiskPolitical Risk
Intelligence on key political and geopolitical events around the world.
- About Us
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
ANZ note that "in the near term, euro weakness may run further as January's exceptionally high core inflation print (1.4% y/y, the highest in five years) has helped to push real yields down. The slow rollout of the vaccine program across the European Union is also weighing on sentiment. However, our business cycle analysis implies that euro weakness should prove temporary and that the move is corrective in nature. The slow start to vaccinations will correct as serum production improves. The net effect will be to push a recovery in aggregate demand into late spring and summer rather than Q1. Whilst that delay to the anticipated rebound is frustrating, positive cyclical developments will re-emerge to support the euro as 2021 progresses."